188 related articles for article (PubMed ID: 1306646)
1. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.
Rübo J; Albrecht K; Lasch P; Laufkötter E; Leititis J; Marsan D; Niemeyer B; Roesler J; Roll C; Roth B
J Pediatr; 1992 Jul; 121(1):93-7. PubMed ID: 1306646
[TBL] [Abstract][Full Text] [Related]
2. [High-dose immunoglobulin therapy of hyperbilirubinemia in rhesus incompatibility].
Rübo J; Wahn V
Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():104-8; discussion 109. PubMed ID: 8499737
[TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice.
Alpay F; Sarici SU; Okutan V; Erdem G; Ozcan O; Gökçay E
Acta Paediatr; 1999 Feb; 88(2):216-9. PubMed ID: 10102158
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
[TBL] [Abstract][Full Text] [Related]
5. Intravenous immunoglobulin therapy for hyperbilirubinemia caused by Rhesus hemolytic disease.
Merchant RH; Pradeep S
Indian Pediatr; 1994 Oct; 31(10):1269-71. PubMed ID: 7875791
[No Abstract] [Full Text] [Related]
6. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
[TBL] [Abstract][Full Text] [Related]
7. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
Kappas A; Drummond GS; Munson DP; Marshall JR
Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn.
Nasseri F; Mamouri GA; Babaei H
Saudi Med J; 2006 Dec; 27(12):1827-30. PubMed ID: 17143357
[TBL] [Abstract][Full Text] [Related]
9. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease.
Voto LS; Sexer H; Ferreiro G; Tavosnanska J; Orti J; Mathet ER; Margulies M; Margulies M
J Perinat Med; 1995; 23(6):443-51. PubMed ID: 8904473
[TBL] [Abstract][Full Text] [Related]
10. Exchange transfusion in newborn infants with perinatal hemolytic disease. Efficacy of the procedure.
Ceccon ME; Diniz EM; Ramos JL; Vaz FA
Rev Paul Med; 1993; 111(2):348-53. PubMed ID: 8284577
[TBL] [Abstract][Full Text] [Related]
11. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn.
Gottstein R; Cooke RW
Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F6-10. PubMed ID: 12496219
[TBL] [Abstract][Full Text] [Related]
12. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease.
Dağoğlu T; Ovali F; Samanci N; Bengisu E
J Int Med Res; 1995; 23(4):264-71. PubMed ID: 7589769
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial.
Santos MC; Sá C; Gomes SC; Camacho LA; Moreira ME
Transfusion; 2013 Apr; 53(4):777-82. PubMed ID: 22882285
[TBL] [Abstract][Full Text] [Related]
14. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn--a prospective randomized controlled trial.
Elalfy MS; Elbarbary NS; Abaza HW
Eur J Pediatr; 2011 Apr; 170(4):461-7. PubMed ID: 20924607
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and AB0 incompatibility.
Huizing K; Røislien J; Hansen T
Acta Paediatr; 2008 Oct; 97(10):1362-5. PubMed ID: 18616629
[TBL] [Abstract][Full Text] [Related]
16. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility].
Li ZH; Wang J; Chen C
Zhonghua Er Ke Za Zhi; 2010 Sep; 48(9):656-60. PubMed ID: 21092522
[TBL] [Abstract][Full Text] [Related]
17. The effect of phototherapy on the hyperbilirubinemia of rhesus incompatibility.
Shennan AT
Pediatrics; 1974 Oct; 54(4):417-22. PubMed ID: 4213433
[No Abstract] [Full Text] [Related]
18. Severe hemolytic disease of the newborn caused by anti-Gonzales antibody.
Leschek E; Pearlman SA; Boudreaux I; Meek R
Am J Perinatol; 1993 Sep; 10(5):362-4. PubMed ID: 8240594
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Bilirubin According to the Results of the Direct Antiglobulin Test and Its Impact in Hemolytic Disease of the Newborn.
Shin KH; Lee HJ; Song D; Lee SM; Kim IS; Kim H; Yang EJ; Park KH
Lab Med; 2019 Apr; 50(2):138-144. PubMed ID: 30192966
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin in the management of hemolytic disease of the newborn.
Mundy CA
Neonatal Netw; 2005; 24(6):17-24. PubMed ID: 16383181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
